The present invention provides for a proteomic approach to classifying glomerular tissue as normal, non-sclerotic or sclerotic. In particular, the proteomic approach may employ laser capture microdissection followed by MALDI-TOF. A particular target of interest that is highly relevant in distinguishing such tissues is thymosin .beta.4.

 
Web www.patentalert.com

< Protein scaffolds and uses thereof

< Quinoline Derivatives as NK-3 Antagonists

> Indole derivatives as somatostatin agonists or antagonists

> Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
~ 00293